Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
76 GBX | -.--% | -.--% | +0.66% |
12:34pm | Biotech Growth beats benchmark | AN |
11:46am | Biotech Growth Trust beats benchmark | AN |
Sales 2024 * | 357M 457M 38.05B | Sales 2025 * | 382M 488M 40.69B | Capitalization | 282M 361M 30.06B |
---|---|---|---|---|---|
Net income 2024 * | 20M 25.59M 2.13B | Net income 2025 * | 25M 31.98M 2.67B | EV / Sales 2024 * | 1.01 x |
Net Debt 2024 * | 78.83M 101M 8.41B | Net Debt 2025 * | 82.97M 106M 8.85B | EV / Sales 2025 * | 0.96 x |
P/E ratio 2024 * |
14.4
x | P/E ratio 2025 * |
11.8
x | Employees | 456 |
Yield 2024 * |
3.7% | Yield 2025 * |
3.93% | Free-Float | 31.46% |
Latest transcript on Henry Boot PLC
3 months | +0.66% | ||
6 months | +0.66% | ||
Current year | +0.66% |
Managers | Title | Age | Since |
---|---|---|---|
Tim Roberts
CEO | Chief Executive Officer | 59 | 01/20/01 |
Director of Finance/CFO | 49 | 01/98/01 | |
Amy Stanbridge
IRO | Public Communications Contact | - | 01/18/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Tim Roberts
CEO | Chief Executive Officer | 59 | 01/20/01 |
Joanne Lake
BRD | Director/Board Member | 61 | 01/15/01 |
Jonathan Sykes
BRD | Director/Board Member | 59 | 01/11/01 |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+0.26% | 70.46B | |
-3.33% | 55.99B | |
+25.13% | 39.53B | |
+17.88% | 32.6B | |
+10.36% | 29.09B | |
+17.43% | 21.31B | |
+11.17% | 18.82B | |
+38.22% | 17.52B | |
+71.23% | 17.34B |
- Stock Market
- Equities
- BHY Stock
- BD82 Stock